• Latest Posts
Startup Scout 19 Dec 2022

Green Bioactives grows medicines in plant cells

Beyond Biotech podcast 26: CellCentric, MicrofluidX, Potter Clarkson

Alchemab Therapeutics receives £1.7M grant to work on therapy for Huntington’s disease

STORM Therapeutics closes $30M Series B financing

Planning application submitted for Europe’s largest life sciences building

Tachmed aiming to make healthcare more accessible

ADVERTISEMENT

Blood clotting research holds hope for sepsis

Opinion 12 Dec 2022

Artificial intelligence: a new era in rare genetic disease diagnosis

New targeted drug shows benefit against breast cancer in first phase III trial

The Native Antigen Company expands infectious disease portfolio

MicrofluidX raises £3.3M to develop advanced therapy manufacturing platform

Allergy Therapeutics moves ahead with peanut and grass pollen allergy trials

ADVERTISEMENT